drugset / Trial / NCT01112085
MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2)
Phase 2
Completed
72 enrolled
Especialistas en Retina Medica y Quirurgica Grupo de Investigacion
Centro de Retina Medica y Quirurgica S.C. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of this study is to investigate if the drug ranibizumab administrated by microdose injection into the eye is safe and effective to treat diabetic macular edema.
Timeline
- Start
- 2010-04
- Primary completion
- 2014-01
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.05 mg | Intravitreal |
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |